LiveIndia Ponders Over Prohibiting 250 Chinese Apps, Includes PubG
After declaring a ban on Bytedance’s TikTok along with 59 other apps, Indian Government is pondering over banning 275 more Chinese apps including PubG backed...
Category : INDIA
Kargil Vijay Diwas: PM Modi Pays Respect to Martyrs
PM Narendra Modi, on Sunday, censured Pakistan for the Kargil War. He said that the neighbouring nation had attempted to betray India when India was making efforts...
Apple Begins Manufacturing iPhone 11 in Chennai
Chennai’s Foxconn plant is a leading supplier for Apple and has planned to invest up to $1 billion in the expansion of its India factory...
Google to Take No Commissions From its Sellers
Google has announced that it will be charging no fees for the sellers to list products on Google Shopping. It will provide a commission-free marketplace where sellers...
RIL Becomes First Indian Company With Market Value Of Rs 13 Trillion
Reliance Industries Limited (RIL) has crossed the Rs 13 lakh crore mark in Thursday’s trading session as the company’s shares rose nearly 4 per cent in...
Covid-19’s Third Vaccine Undergoes Final Trial
Researches across the world are working against time to develop and test a ready-to-use vaccine for the coronavirus, with over 150 projects by far.Based on...
Tiktok’s New plan Include Adding 10K US Jobs in 3 Years
Tiktok, the vastly popular smartphone app among the youth and other audiences; estimated to have reached the billion-user mark worldwide – has faced allegations of...
Railways: Bhuj Station Being Redeveloped by RLDA
The proposal to appoint a consultant to redevelopment Bhuj railway station in Gujarat; as called by Rail Land Development Authority (RLDA), a statutory body under railways...
Covid-19: India Cases Exceed 11.5 Lakh, 24,000 Patients Cured in a Day
Statistics reveal that 402509 Covid-19 cases remain active in India, with 724577 recovered patients and one migration. The recovery rate thus stands at 62.72%. In...
Covid-19 Vaccine – AIIMS Delhi to Launch Covaxin Human Clinical Trials
The All India Institute of Medical Science (AIIMS) is prepared to behind human trials today for the indigenous COVID-19 vaccine candidate, Covaxin, after being approved by its...